Suppression of iron-regulatory hepcidin by vitamin D

Journal of the American Society of Nephrology

Volumn 25, Issue 3, 2014, Pages 564-572

  Bacchetta, Justine ^a,b,c   Zaritsky, Joshua J ^b   Sea, Jessica L ^a   Chun, Rene F ^a   Lisse, Thomas S ^a   Zavala, Kathryn ^a   Nayak, Anjali ^b   Wesseling Perry, Katherine ^b   Westerman, Mark ^d   Hollis, Bruce W ^e   Salusky, Isidro B ^b   Hewison, Martin ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITÉ DE LYON   (France)

^d Intrinsic Life Sciences   (United States)

^e MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL; CATHELICIDIN; ERGOCALCIFEROL; FERRITIN; FERROPORTIN; HEPCIDIN; HORMONE PRECURSOR; MESSENGER RNA; VITAMIN D; VITAMIN D RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; COMPARATIVE STUDY; CONTROLLED STUDY; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HOMEOSTASIS; HUMAN; HUMAN CELL; IRON BINDING CAPACITY; LIVER CELL; MALE; METABOLITE; MONOCYTE; MOUSE; NONHUMAN; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PILOT STUDY; PRIORITY JOURNAL; PROMOTER REGION; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SINGLE DRUG DOSE; TRANSCRIPTION REGULATION; VITAMIN BLOOD LEVEL; VITAMIN D RESPONSIVE ELEMENT; VITAMIN SUPPLEMENTATION;

3T3 CELLS; ADULT; ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; CATION TRANSPORT PROTEINS; FEMALE; FERRITINS; HEALTHY VOLUNTEERS; HEP G2 CELLS; HEPCIDINS; HUMANS; MALE; MICE; MIDDLE AGED; PILOT PROJECTS; VITAMIN D;

EID: 84896810942     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2013040355     Document Type: Article

References (48)

1. Kalantar-Zadeh K, Streja E, Miller JE, Nissenson AR: Intravenous iron versus erythropoiesis-stimulating agents: Friends or foes in treating chronic kidney disease anemia? Adv Chronic Kidney Dis 16: 143-151, 2009
2. Nakanishi T, Hasuike Y, Otaki Y, Kida A, Nonoguchi H, Kuragano T: Hepcidin: another culprit for complications in patients with chronic kidney disease? Nephrol Dial Transplant 26: 3092-3100, 2011
3. Ganz T: Hepcidin and iron regulation, 10 years later. Blood 117: 4425-4433, 2011
4. Young B, Zaritsky J: Hepcidin for clinicians. Clin J Am Soc Nephrol 4: 1384-1387, 2009
5. Ganz T: Hepcidin, a key regulator of iron metabolism and mediator of anemia of in flammation. Blood 102: 783-788, 2003
6. Ramos E, Kautz L, Rodriguez R, Hansen M, Gabayan V, Ginzburg Y, Roth MP, Nemeth E, Ganz T: Evidence for distinct pathways of hepcidin regulation by acute and chronic iron loading in mice. Hepatology 53: 1333-1341, 2011
7. Lac PT, Choi K, Liu IA, Meguerditchian S, Rasgon SA, Sim JJ: The effects of changing vitamin D levels on anemia in chronic kidney disease patients: A retrospective cohort review. Clin Nephrol 74: 25-32, 2010
8. Kiss Z, Ambrus C, Almasi C, Berta K, Deak G, Horonyi P, Kiss I, Lakatos P, Marton A, Molnar MZ, Nemeth Z, Szabo A, Mucsi I: Serum 25(OH)-cholecalciferol concentration is associated with hemoglobin level and erythropoietin resistance in patients on maintenance hemodialysis. Nephron Clin Pract 117: c373 - c378, 2011
9. Kumar VA, Kujubu DA, Sim JJ, Rasgon SA, Yang PS: Vitamin D supplementation and recombinant human erythropoietin utilization in vitamin D-deficient hemodialysis patients. J Nephrol 24: 98-105, 2011
10. Rianthavorn P, Boonyapapong P: Ergocalciferol decreases erythropoietin resistance in children with chronic kidney disease stage 5. Pediatr Nephrol 28: 1261-1266, 2013
11. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, Ochoa MT, Schauber J, Wu K, Meinken C, Kamen DL, Wagner M, Bals R, Steinmeyer A, Zügel U, Gallo RL, Eisenberg D, Hewison M, Hollis BW, Adams JS, Bloom BR, Modlin RL: Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311: 1770-1773, 2006
12. Adams JS, Ren S, Liu PT, Chun RF, Lagishetty V, Gombart AF, Borregaard N, Modlin RL, Hewison M: Vitamin D-directed rheostatic regulation ofmonocyte antibacterial responses. J Immunol 182: 4289-4295, 2009
13. Hewison M: Antibacterial effects of vitamin D. Nat Rev Endocrinol 7: 337-345, 2011
14. Wang TT, Nestel FP, Bourdeau V, Nagai Y, Wang Q, Liao J, Tavera-Mendoza L, Lin R, Hanrahan JW, Mader S, White JH: Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol 173: 2909-2912, 2004
15. Gombart AF, Borregaard N, Koeffler HP: Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB J 19: 1067-1077, 2005 (Pubitemid 40946432)
16. Gombart AF, Saito T, Koef fler HP: Exaptation of an ancient Alu short interspersed element provides a highly conserved vitamin D-mediated innate immune response in humans and primates. BMC Genomics 10: 321, 2009
17. Gal-Tanamy M, Bachmetov L, Ravid A, Koren R, Erman A, Tur-Kaspa R, Zemel R: Vitamin D: An innate antiviral agent suppressing hepatitis C virus in human hepatocytes. Hepatology 54: 1570- 1579, 2011
18. Hewison M: Vitamin D and the intracrinology of innate immunity. Mol Cell Endocrinol 321: 103-111, 2010
19. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, Kaplan J: Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306: 2090-2093, 2004 (Pubitemid 40007660)
20. Wang L, Cherayil BJ: Ironing out the wrinkles in host defense: Interactions between iron homeostasis and innate immunity. J Innate Immun 1: 455-464, 2009
21. Drakesmith H, Prentice AM: Hepcidin and the iron-infection axis. Science 338: 768-772, 2012
22. Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, Ganz T: Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 101: 2461-2463, 2003 (Pubitemid 36857598)
23. Nairz M, Theurl I, Ludwiczek S, Theur lM, Mair SM, Fritsche G, Weiss G: The co-ordinated regulation of iron homeostasis in murine macrophages limits the availability of iron for intracellular Salmonella typhimurium. Cell Microbiol 9: 2126-2140, 2007 (Pubitemid 47250286)
24. Schaible UE, Collins HL, Priem F, Kaufmann SH: Correction of the iron overload defect in beta-2-microglobulin knockout mice by lactoferrin abolishes their increased susceptibility to tuberculosis. J Exp Med 196: 1507-1513, 2002 (Pubitemid 35424944)
25. Sow FB, Alvarez GR, Gross RP, Satoskar AR, Schlesinger LS, Zwilling BS, Lafuse WP: Role of STAT1, NF-kappaB, and C/EBPbeta in the macrophage transcriptional regulation of hepcidin by mycobacterial infection and IFN-gamma. J Leukoc Biol 86: 1247-1258, 2009
26. Sow FB, Florence WC, Satoskar AR, Schlesinger LS, Zwilling BS, Lafuse WP: Expression and localization of hepcidin in macrophages: A role in host defense against tuberculosis. J Leukoc Biol 82: 934 945, 2007
27. Paradkar PN, De Domenico I, Durchfort N, Zohn I, Kaplan J, Ward DM: Iron depletion limits intracellular bacterial growth in macrophages. Blood 112: 866-874, 2008
28. Armitage AE, Eddowes LA, Gileadi U, Cole S, Spottiswoode N, Selvakumar TA, Ho LP, Townsend AR, Drakesmith H: Hepcidin regulation by innate immune and infectious stimuli. Blood 118: 4129-4139, 2011
29. Adams JS, Hewison M: Unexpected actions of vitamin D: New perspectives on the regulation of innate and adaptive immunity. Nat Clin Pract Endocrinol Metab 4: 80-90, 2008 (Pubitemid 351156900)
30. Yuk JM, Shin DM, Lee HM, Yang CS, Jin HS, Kim KK, Lee ZW, Lee SH, Kim JM, Jo EK: Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin. Cell Host Microbe 6: 231-243, 2009
31. Shin DM, Yuk JM, Lee HM, Lee SH, Son JW, Harding CV, Kim JM, Modlin RL, Jo EK: Mycobacterial lipoprotein activates autophagy via TLR2/1/CD14 and a functional vitamin D receptor signalling. Cell Microbiol 12: 1648-1665, 2010
32. Ganz T, Nemeth E: Iron sequestration and anemia of inflammation. Semin Hematol 46: 387-393, 2009
33. Andrews NC: Anemia of inflammation: The cytokine-hepcidin link. J Clin Invest 113: 1251-1253, 2004
34. Sun CC, Vaja V, Babitt JL, Lin HY: Targeting the hepcidin-ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammation. Am J Hematol 87: 392-400, 2012
35. Babitt JL, Lin HY: Molecular mechanisms of hepcidin regulation: implications for the anemia of CKD. Am J Kidney Dis 55: 726-741, 2010
36. Sasu BJ, Cooke KS, Arvedson TL, Plewa C, Ellison AR, Sheng J, Winters A, Juan T, Li H, Begley CG, Molineux G: Antihepcidin antibody treatment modulates iron metabolism and is effective in a mouse model of inflammation-induced anemia. Blood 115: 3616-3624, 2010
37. Schwoebel F, van Eijk LT, Zboralski D, Sell S, Buchner K, Maasch C, Purschke WG, Humphrey M, Zöllner S, Eulberg D, Morich F, Pickkers P, Klussmann S: The effects of the anti-hepcidin Spiegelmer NOX-H94 on inflammation-induced anemia in cynomolgus monkeys. Blood 121: 2311-2315, 2013
38. Theurl I, Schroll A, Sonnweber T, Nairz M, Theurl M, Willenbacher W, Eller K, Wolf D, Seifert M, Sun CC, Babitt JL, Hong CC, Menhall T, Gearing P, Lin HY, Weiss G: Pharmacologic inhibition of hepcidin expression reverses anemia of chronic in flammation in rats. Blood 118: 4977-4984, 2011
39. Song SN, Tomosugi N, Kawabata H, Ishikawa T, Nishikawa T, Yoshizaki K: Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease. Blood 116: 3627-3634, 2010
40. Bachman E, Feng R, Travison T, Li M, Olbina G, Ostland V, Ulloor J, Zhang A, Basaria S, Ganz T, Westerman M, Bhasin S: Testosterone suppresses hepcidin in men: A potential mechanism for testosterone-induced erythrocytosis. J Clin Endocrinol Metab 95: 4743-4747, 2010
41. Pilz S, Iodice S, Zittermann A, Grant WB, Gandini S: Vitamin D status and mortality risk in CKD: a meta-analysis of prospective studies. Am J Kidney Dis 58: 374-382, 2011
42. Chun RF, Lauridsen AL, Suon L, Zella LA, Pike JW, Modlin RL, Martineau AR, Wilkinson RJ, Adams J, Hewison M: Vitamin D-binding protein directsmonocyte responses to 25-hydroxy- and 1,25-dihydroxyvitamin D. J Clin Endocrinol Metab 95: 3368-3376, 2010
43. Lagishetty V, Misharin AV, Liu NQ, Lisse TS, Chun RF, Ouyang Y, McLachlan SM, Adams JS, Hewison M: Vitamin D de ficiency in mice impairs colonic antibacterial activity and predisposes to colitis. Endocrinology 151: 2423-2432, 2010
44. 125I-labeled tracer. Clin Chem 39: 529-533, 1993
45. 125I-labeled tracer. Clin Chem 42: 586-592, 1996
46. Bacchetta J, Sea JL, Chun RF, Lisse TS, Wesseling-Perry K, Gales B, Adams JS, Salusky IB, Hewison M: Fibroblast growth factor 23 inhibits extrarenal synthesis of 1,25-dihydroxyvitamin D in human monocytes. J Bone Miner Res 28: 46-55, 2013
47. Lisse TS, Liu T, Irmler M, Beckers J, Chen H, Adams JS, Hewison M: Gene targeting by the vitamin D response element binding protein reveals a role for vitamin D in osteoblast mTOR signaling. FASEB J 25: 937-947, 2011
48. Maes K, Nemeth E, Roodman GD, Huston A, Esteve F, Freytes C, Callander N, Katodritou E, Tussing-Humphreys L, Rivera S, Vanderkerken K, Lichtenstein A, Ganz T: In anemia of multiple myeloma, hepcidin is induced by increased bone morphogenetic protein 2. Blood 116: 3635-3644, 2010